**Eli Lilly and Company (LLY)** reported significant earnings growth, with a projected earnings of **$9.01 per share** for the current quarter, reflecting a **42.8%** increase year-over-year. For the fiscal year, expected earnings are set at **$35.67**, which is **47.3%** higher compared to last year. The consensus sales estimate for the current quarter is **$20.44 billion**, indicating a **31.4%** year-over-year growth.
The company’s stock has shown a strong performance recently, returning **19.3%** over the past month, compared to the **1.9%** increase in the S&P 500. Lilly’s **Zacks Rank #3 (Hold)** rating suggests it may perform in line with the broader market in the near term.
In its last reported quarter, Lilly achieved revenues of **$19.8 billion**, surpassing the consensus estimate of **$17.62 billion** by **12.37%** and posting an impressive **55.5%** year-over-year increase.
5 Stocks Our Experts Predict Could Double In the Next Year
By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.
